メタゲノミクスの市場規模、シェア、動向分析レポート：製品別、技術別、ワークフロー別、用途別、地域別、セグメント予測、2024年～2030年

メタゲノミクス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のメタゲノミクス市場規模は2030年までに48億2,000万米ドルに達する見込みです。

2024年から2030年までのCAGRは13.52%で市場は拡大する見込みです。ゲノミクスとプロテオミクスの研究の増加、個別化医薬品の採用の増加、生物学的製剤への要求の高まりがシーケンサーの需要を促進しており、業界の成長を後押ししています。例えば、2022年8月、Illumina, Inc.は、ソリューションセンターを開発することで、ブラジルでゲノミクス事業を拡大する計画を発表しました。新施設の設立は、臨床ゲノミクスに対する需要の高まりとラテンアメリカにおける同社の足跡を加速する結果です。

各社による研究開発投資の活発化は、多くのアプリケーションにおけるメタゲノミクスの利用に大きな影響を与えると推定されます。例えば、2021年4月、Agilent Technologies, Inc.は、NGSベースの精密腫瘍学ソリューション開発企業であるResolution Bioscience, Inc.を買収しました。Resolution Bioscienceの非侵襲的リキッドバイオプシープラットフォームとAgilentの組織ベースのコンパニオン診断薬の組み合わせは、プレシジョンオンコロジー向けNGS技術におけるアジレントの市場ポジションを拡大すると予想されます。

メタゲノミクスが環境用途に多く採用されているもう一つの要因は、微生物が生物地球化学サイクルに直接関与していることです。微生物による石油炭化水素などの炭素源の分解は、研究者にバイオ燃料生産のためのメタゲノミクスプロセスの研究を促しています。さらに、非培養微生物に未発見の生体分子が多数存在することから、農業、食品安全、化学、工業、その他の関連用途でメタゲノミクスの導入が加速しました。

COVID-19の発生以来、ライフサイエンスおよびバイオテクノロジー業界の主要利害関係者は、COVID-19の追跡、検出、治療のためのソリューションを求めています。メタゲノミクス解析は、ウイルスの検出と追跡において重要な役割を果たしています。感染の効果的な診断のために、様々なシーケンス監視プラットフォームとソリューションが展開されています。例えば、2021年5月、オックスフォード大学とオラクルは、コロナウイルス感染リスクを軽減するための堅牢なクラウドベースのゲノムシーケンスおよび解析プラットフォームを開発するための戦略的パートナーシップを発表しました。

さらに、NGSプラットフォームを使用する学術機関の研究を促進するために政府から提供される資金は、メタゲノミクスツールの利用をさらに増加させる。例えば、2021年2月、カナダ政府はCOVID-19の診断のための多層的アプローチを実施するために5,300万米ドルを投資しました。カナダ政府は、ゲノム配列決定と解析技術を活用して、望ましい結果を達成する予定です。

メタゲノミクスによって生成されるデータの質も、解析コストを増大させる要因のひとつです。データの質は塩基配列決定プロセスにおける平均実行回数に大きく依存します。高品質の解析にはコストがかかります。しかし、RNA-Seqのような新しい技術の採用は、価格の低下とともに、正確さと迅速な結果によって急速に増加しています。シーケンシングのコストは毎年5～10倍に、計算能力は2年ごとに2倍になることが確認されています。

メタゲノミクス市場レポートハイライト

• キット・試薬セグメントは、2023年に61.48%以上の最大収益シェアを占めました。キット&試薬は、土壌、水、生物学的サンプル分析などの特定用途向けに設計されています。
• ショットガンシーケンスセグメントは、2023年に34.08%の最大の収益シェアを占めました。ショットガンシーケンスは、DNAをランダムに小さな断片に分割し、各断片をシーケンスすることでゲノム全体をシーケンスします。
• シーケンシングセグメントは、2023年に53.39%の収益シェアを占め、市場を独占しました。この増加は、シーケンシングの技術的進歩によって達成された費用対効果と精度に起因しています。
• 2023年には、環境セグメントが25.02%の収益シェアで市場を独占しました。メタゲノム研究の役割は、農業や環境保護において急速に拡大しており、シーケンス分析や遺伝子スクリーニングを採用して特定の環境内の微生物を理解し、微生物生態系を理解するための新しいアプローチを示しています。
• 2023年のメタゲノミクス市場は、北米が40.26％の収益シェアで支配的でした。この地域の優位性は、主要企業の存在、研究開発資金の増強、シーケンス技術の進歩によって決定されます。
• アジア太平洋地域は、予測期間中に最も速いCAGRで成長すると予想されています。これは、インドと中国における多様なアプリケーションでのメタゲノミクス採用の大幅な進歩が原動力です。

目次

第1章 メタゲノミクス市場：調査手法と範囲

第2章 メタゲノミクス市場：エグゼクティブサマリー

• 市場スナップショット
• セグメントスナップショット
• 競合情勢のスナップショット

第3章 メタゲノミクス市場：変数、動向、範囲

• 市場系統の見通し
• 市場動向と展望
• 市場力学
• 市場抑制要因分析
• ビジネス環境分析
• COVID-19影響分析

第4章 メタゲノミクス市場：製品のビジネス分析

• セグメントダッシュボード
• 世界のメタゲノミクス市場：製品の変動分析
• 世界のメタゲノミクス市場規模・動向分析、製品別、2018～2030年

第5章 メタゲノミクス市場：技術のビジネス分析

• セグメントダッシュボード
• 世界のメタゲノミクス市場：技術の変動分析
• 世界のメタゲノミクス市場規模・動向分析、技術別、2018～2030年

第6章 メタゲノミクス市場：ワークフローのビジネス分析

• セグメントダッシュボード
• 世界のメタゲノミクス市場：ワークフローの変動分析
• 世界のメタゲノミクス市場規模・動向分析、ワークフロー別、2018～2030年

第7章 メタゲノミクス市場：用途のビジネス分析

• セグメントダッシュボード
• 世界のメタゲノミクス市場：用途の変動分析
• 世界のメタゲノミクス市場規模・動向分析、用途別、2018～2030年

第8章 地域のビジネス分析

• 地域のダッシュボード
• 市場規模と予測・動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • 韓国
  • タイ
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 参入企業
• 戦略マッピング
• 企業市況分析、2023年
• 参入企業の概要
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc
  • Thermo Fisher Scientific, Inc
  • Novogene Co., Ltd.
  • Promega Corporation
  • QIAGEN
  • Takara Bio, Inc.
  • Oxford Nanopore Technologies plc.
  • F. Hoffmann-La Roche Ltd.

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 4 Global Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 5 Global Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 6 Global Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 7 Global Sexual Health Supplements Market, By Region, 2018 - 2030 (USD Million)
• Table 8 North America Metagenomics Market, Region, 2018 - 2030 (USD Million)
• Table 9 North America Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 10 North America Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 11 North America Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 12 North America Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 13 U.S. Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 14 U.S. Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 15 U.S. Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 16 U.S. Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 17 Canada Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 18 Canada Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 19 Canada Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 20 Canada Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 21 Europe Metagenomics Market, Region, 2018 - 2030 (USD Million)
• Table 22 Europe Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 23 Europe Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 24 Europe Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 25 Europe Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 26 UK Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 27 UK Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 28 UK Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 29 UK Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 30 Germany Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 31 Germany Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 32 Germany Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 33 Germany Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 34 France Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 35 France Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 36 France Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 37 France Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 38 Italy Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 39 Italy Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 40 Italy Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 41 Italy Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 42 Spain Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 43 Spain Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 44 Spain Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 45 Spain Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 46 Sweden Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 47 Sweden Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 48 Sweden Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 49 Sweden Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 50 Norway Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 51 Norway Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 52 Norway Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 53 Norway Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 54 Denmark Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 55 Denmark Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 56 Denmark Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 57 Denmark Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific Metagenomics Market, Region, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 63 Japan Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 64 Japan Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 65 Japan Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 66 Japan Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 67 China Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 68 China Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 69 China Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 70 China Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 71 India Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 72 India Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 73 India Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 74 India Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 75 Australia Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 76 Australia Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 77 Australia Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 78 Australia Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 79 South Korea Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 80 South Korea Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 81 South Korea Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 82 South Korea Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 83 Thailand Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 84 Thailand Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 85 Thailand Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 86 Thailand Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 87 Latin America Metagenomics Market, Region, 2018 - 2030 (USD Million)
• Table 88 Latin America Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 89 Latin America Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 90 Latin America Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 91 Latin America Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 92 Brazil Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 93 Brazil Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 94 Brazil Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 95 Brazil Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 96 Mexico Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 97 Mexico Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 98 Mexico Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 99 Mexico Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 100 Argentina Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 101 Argentina Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 102 Argentina Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 103 Argentina Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 104 MEA Metagenomics Market, Region, 2018 - 2030 (USD Million)
• Table 105 MEA Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 106 MEA Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 107 MEA Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 108 MEA Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 109 South Africa Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 110 South Africa Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 111 South Africa Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 112 South Africa Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 117 UAE Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 118 UAE Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 119 UAE Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 120 UAE Metagenomics Market, By Application, 2018 - 2030 (USD Million)
• Table 121 Kuwait Metagenomics Market, By Product, 2018 - 2030 (USD Million)
• Table 122 Kuwait Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
• Table 123 Kuwait Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
• Table 124 Kuwait Metagenomics Market, By Application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Metagenomics market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Parent market outlook
• Fig. 13 Sexual health supplements market driver analysis
• Fig. 14 Metagenomics market restraint analysis
• Fig. 15 Metagenomics market: Porter's analysis
• Fig. 16 Metagenomics market: PESTEL analysis
• Fig. 17 Metagenomics market: Technology outlook and key takeaways
• Fig. 18 Metagenomics market: Technology market share analysis, 2023 - 2030
• Fig. 19 Global metagenomics by shotgun sequencing market, 2018 - 2030 (USD Million)
• Fig. 20 Global metagenomics by 16S sequencing market, 2018 - 2030 (USD Million)
• Fig. 21 Global metagenomics by whole genome sequencing market, 2018 - 2030 (USD Million)
• Fig. 22 Global metagenomics by others market, 2018 - 2030 (USD Million)
• Fig. 23 Metagenomics market: Product outlook and key takeaways
• Fig. 24 Metagenomics market: Product market share analysis, 2023 - 2030
• Fig. 25 Global metagenomics by kits & reagents market, 2018 - 2030 (USD Million)
• Fig. 26 Global metagenomics by sequencing & data analytics services market, 2018 - 2030 (USD Million)
• Fig. 27 Global metagenomics by software market, 2018 - 2030 (USD Million)
• Fig. 28 Metagenomics market: Application outlook and key takeaways
• Fig. 29 Metagenomics market: Application market share analysis, 2023 - 2030
• Fig. 30 Global metagenomics by environmental market, 2018 - 2030 (USD Million)
• Fig. 31 Global metagenomics by clinical diagnostics market, 2018 - 2030 (USD Million)
• Fig. 32 Global metagenomics by drug discovery market, 2018 - 2030 (USD Million)
• Fig. 33 Global metagenomics by biotechnology market, 2018 - 2030 (USD Million)
• Fig. 34 Global metagenomics by food & nutrition market, 2018 - 2030 (USD Million)
• Fig. 35 Global metagenomics by others market, 2018 - 2030 (USD Million)
• Fig. 36 Metagenomics market: Workflow outlook and key takeaways
• Fig. 37 Metagenomics market: Workflow market share analysis, 2023 - 2030
• Fig. 38 Global metagenomics by pre-sequencing market, 2018 - 2030 (USD Million)
• Fig. 39 Global metagenomics by sequencing market, 2018 - 2030 (USD Million)
• Fig. 40 Global metagenomics by data analysis market, 2018 - 2030 (USD Million)
• Fig. 41 Regional marketplace: Key takeaways
• Fig. 42 North America metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 U.S. key country dynamics
• Fig. 44 U.S. metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 Canada key country dynamics
• Fig. 46 Canada metagenomics market, 2018 - 2030 (USD Million)
• Fig. 47 Europe metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 UK key country dynamics
• Fig. 49 UK metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 50 Germany key country dynamics
• Fig. 51 Germany metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 France key country dynamics
• Fig. 53 France metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 Italy key country dynamics
• Fig. 55 Italy metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Spain key country dynamics
• Fig. 57 Spain metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Denmark key country dynamics
• Fig. 59 Denmark metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 Sweden key country dynamics
• Fig. 61 Sweden metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 Norway key country dynamics
• Fig. 63 Norway metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 Asia-Pacific metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Japan key country dynamics
• Fig. 66 Japan metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 China key country dynamics
• Fig. 68 China metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 India key country dynamics
• Fig. 70 India metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 Australia key country dynamics
• Fig. 72 Australia metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 73 Thailand key country dynamics
• Fig. 74 Thailand metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 South Korea key country dynamics
• Fig. 76 South Korea metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 77 Latin America metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 Brazil key country dynamics
• Fig. 79 Brazil metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 Mexico key country dynamics
• Fig. 81 Mexico metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 82 Argentina key country dynamics
• Fig. 83 Argentina metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 84 MEA metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 85 South Africa key country dynamics
• Fig. 86 South Africa metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 87 Saudi Arabia key country dynamics
• Fig. 88 Saudi Arabia metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 89 UAE key country dynamics
• Fig. 90 UAE metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 91 Kuwait key country dynamics
• Fig. 92 Kuwait metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 93 Key company categorization
• Fig. 94 Company market positioning
• Fig. 95 Market participant categorization
• Fig. 96 Strategy framework

Metagenomics Market Growth & Trends:

The global metagenomics market size is expected to reach USD 4.82 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.52% from 2024 to 2030. The increasing research in genomics and proteomics, the rising adoption of personalized medicines, and escalating requirement for biologic products are driving the demand for sequencing, fueling the growth of the industry. For instance, in August 2022, Illumina, Inc. announced its plans to expand genomics operations in Brazil by developing a solution center. The establishment of the new facility is the result of rising demand for clinical genomics and accelerating the company's footprint in Latin America.

A boost in R&D investments by the players is estimated to have a considerable impact on the usage of metagenomics in numerous applications. For instance, in April 2021, Agilent Technologies, Inc. acquired Resolution Bioscience, Inc., an NGS-based precision oncology solution developing company. The combination of Resolution Bioscience's noninvasive liquid biopsy platform with Agilent's tissue-based companion diagnostics is anticipated to expand Agilent's market position in NGS technologies for precision oncology.

Another factor contributing to the high adoption of metagenomics for environmental use is the direct involvement of microorganisms in the biogeochemical cycle. The degradation of carbon sources such as petroleum hydrocarbons by microbes has encouraged researchers to study metagenomics processes for the production of biofuels. In addition, the presence of a large number of undiscovered biomolecules in non-cultured microorganisms accelerated the adoption of metagenomics in agriculture, food safety, chemical, industrial, and other related applications.

Since the outbreak of COVID-19, key stakeholders in the life sciences and biotechnology industry are seeking solutions for COVID-19 tracking, detection, and treatment. Metagenomics analysis plays a crucial role in the detection and tracing of the virus. Various sequencing surveillance platforms and solutions are being deployed for effective diagnosis of infection. For instance, in May 2021, Oxford University and Oracle announced a strategic partnership to develop robust cloud-based genomic sequencing and analysis platform to mitigate the risk of coronavirus infection.

Moreover, funds provided by the government for promoting research in academic institutes, which use NGS platforms, further increase the usage of metagenomics tools. For instance, in February 2021, the Canadian government invested USD 53 million to implement a multilayered approach for the diagnosis of COVID-19. The Canadian government will utilize genome sequencing and analysis technologies to achieve desired outcomes.

The quality of data generated through metagenomics is another factor that increases the cost of analysis. The quality of data is highly dependent on the average number of times the bases are run during the sequencing process. The high-quality analysis is expensive. However, the adoption of emerging novel techniques, such as RNA-Seq, is rapidly increasing owing to accuracy and rapid results along with a decline in prices. It is observed that the cost of sequencing falls 5 to 10 times every year and the value of computing power doubles every two years.

Metagenomics Market Report Highlights:

• The kits & reagents segment held the largest revenue share of over 61.48% in 2023. Kits & reagents are designed for specific applications, such as soil, water, and biological sample analysis.
• The shotgun sequencing segment accounted for the largest revenue share of 34.08% in 2023. Shotgun sequencing sequences entire genomes by randomly breaking up DNA into small fragments and then sequencing each fragment.
• The sequencing segment dominated the market with revenue share of 53.39% in 2023. The increase can be attributed to the cost-effectiveness and accuracy achieved through technological advancements in sequencing.
• In 2023, the environmental segment dominated the market with a revenue share of 25.02%. The role of metagenomics research is swiftly expanding in agriculture and environmental protection, employing sequencing analysis or gene screening to comprehend microorganisms within a specific environment, marking a novel approach to understanding microbial ecosystems.
• North America dominated the metagenomics market in 2023 with a revenue share of 40.26%. The region's dominance is determined through the presence of key companies, augmented R&D funding, and advancements in sequencing technology.
• Asia Pacific is expected to grow at the fastest CAGR during the forecast period. This is driven by substantial advancements in metagenomics adoption across diverse applications in India and China.

Table of Contents

Chapter 1. Metagenomics Market: Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Information analysis
  • 1.2.2. Market formulation & data visualization
  • 1.2.3. Data validation & publishing
• 1.3. Research Assumptions
• 1.4. Information Procurement
  • 1.4.1. Primary Research
• 1.5. Information or Data Analysis
• 1.6. Market Formulation & Validation
• 1.7. Market Model
• 1.8. Global Market: CAGR Calculation
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Metagenomics Market: Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Metagenomics Market: Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Declining expenses of sequencing
  • 3.3.2. Developments in biotechnology & bioinformatics techniques
  • 3.3.3. Rising interest in microbial screening for different investigations
  • 3.3.4. Emergence of new fields in genomics that complement metagenomics
• 3.4. Market Restraint Analysis
  • 3.4.1. Limited accessibility to computation and different analytic tools
  • 3.4.2. High overall cost of metagenomics
• 3.5. Business Environment Analysis
  • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.5.2. Porter's Five Forces Analysis
• 3.6. COVID - 19 Impact Analysis

Chapter 4. Metagenomics Market: Product Business Analysis

• 4.1. Segment Dashboard
• 4.2. Global Metagenomics Market Product Movement Analysis
• 4.3. Global Metagenomics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.3.1. Kits and Reagents
    • 4.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 4.3.2. Sequencing & Data Analytics Services
    • 4.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 4.3.3. Software
    • 4.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 5. Metagenomics Market: Technology Business Analysis

• 5.1. Segment Dashboard
• 5.2. Global Metagenomics Market Technology Movement Analysis
• 5.3. Global Metagenomics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.3.1. Shotgun Sequencing
    • 5.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 5.3.2. 16S Sequencing
    • 5.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 5.3.3. Whole Genome Sequencing
    • 5.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 5.3.4. Others
    • 5.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 6. Metagenomics Market: Workflow Business Analysis

• 6.1. Segment Dashboard
• 6.2. Global Metagenomics Market Workflow Movement Analysis
• 6.3. Global Metagenomics Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 6.3.1. Pre-sequencing
    • 6.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.3.2. Sequencing
    • 6.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.3.3. Data Analysis
    • 6.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 7. Metagenomics Market: Application Business Analysis

• 7.1. Segment Dashboard
• 7.2. Global Metagenomics Market Application Movement Analysis
• 7.3. Global Metagenomics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.3.1. Environmental
    • 7.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 7.3.2. Clinical Diagnostics
    • 7.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 7.3.3. Drug Discovery
    • 7.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 7.3.4. Biotechnology
    • 7.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 7.3.5. Food & nutrition
    • 7.3.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 7.3.6. Others
    • 7.3.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 8.3. North America
  • 8.3.1. North America Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Market Estimates And Forecasts 2018 To 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.4.4. Spain
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Spain Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.4.5. France
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. France Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.4.6. Italy
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Italy Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Market Estimates And Forecasts 2018 To 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. JAPAN
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. South Korea Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.5.7. Australia
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Australia Market Estimates And Forecasts 2018 To 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.6.3. Mexico
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Mexico Metagenomics Market, 2018 - 2030 (USD Million)
  • 8.6.4. Argentina
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Argentina Market Estimates And Forecasts 2018 To 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2023
• 9.4. Participant's Overview
  • 9.4.1. Bio-Rad Laboratories, Inc.
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Illumina, Inc.
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. PerkinElmer, Inc
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Thermo Fisher Scientific, Inc
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Novogene Co., Ltd.
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Promega Corporation
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. QIAGEN
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Takara Bio, Inc.
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Oxford Nanopore Technologies plc.
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. F. Hoffmann-La Roche Ltd.
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives